{"disease":{"id":"irritability-associated-with-autism-spectrum-disorder","name":"irritability associated with autism spectrum disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05523895","title":"Pimavanserin for the Treatment of Irritability Associated With Autism Spectrum Disorder","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":237,"lead_sponsor_name":"ACADIA Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT05555615","title":"Extension Study of Pimavanserin in Irritability Associated With Autism Spectrum Disorder","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":209,"lead_sponsor_name":"ACADIA Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT07284745","title":"A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":176,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT07285798","title":"A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":176,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":false},{"nct_id":"NCT04174365","title":"Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":119,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT04258839","title":"Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder for Subjects That Have Completed Participation in 331-201-00148","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":true},{"nct_id":"NCT05733390","title":"A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Jazz Pharmaceuticals","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}